Search - tctmd.com

Displaying 121 - 140 of 287

Sort: Relevancy | Date

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Conference News ESC 2022

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

L.A. McKeown

August 27, 2022

News Daily News

Certain CV Meds Tied to Higher MI Risk in Warmer Weather

Caitlin E. Cox

August 04, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Opinion Off Script

To Save a Dying Mother

Kathryn J. Lindley, MD

June 28, 2022

News Daily News

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

L.A. McKeown

June 23, 2022

News Conference News ESC Heart Failure 2022

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

Shelley Wood

May 26, 2022

News Daily News ESC Heart Failure 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Shelley Wood

May 22, 2022

News Opinion Off Script

Amid Civil War and COVID-19, Cardiology in Sudan Takes Courage and Hope

Nafisa Elsammani, MBBS, MD

April 26, 2022

News Conference News ACC 2022

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

Yael L. Maxwell

April 05, 2022

News Daily News

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

L.A. McKeown

March 22, 2022

News Daily News

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

Shelley Wood

February 22, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Daily News

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

L.A. McKeown

December 17, 2021

News Daily News

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

L.A. McKeown

December 07, 2021

News Conference News TCT 2021

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Michael O'Riordan

November 06, 2021

News Conference News TCT 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Todd Neale

November 04, 2021

News Features

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

Shelley Wood

October 08, 2021

News Conference News HFSA 2021

PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF

Todd Neale

September 13, 2021

News Conference News ESC 2021

GUIDE-HF: Pulmonary Artery Sensor May Help in Mild HF, but COVID-19 Muddies Water

Shelley Wood

August 27, 2021

Advertisement

September 2022 News Roundup

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

Certain CV Meds Tied to Higher MI Risk in Warmer Weather

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

To Save a Dying Mother

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Amid Civil War and COVID-19, Cardiology in Sudan Takes Courage and Hope

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF

GUIDE-HF: Pulmonary Artery Sensor May Help in Mild HF, but COVID-19 Muddies Water

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content